Update on retinoblastoma

Retina

Volumn 24, Issue 6, 2004, Pages 828-848

  Abramson, David H ^a,c   Schefler, Amy C ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Brachytherapy; Cancer; Cryotherapy; Enucleation; External beam radiation; Periocular chemotherapy; Retinoblastoma; Second nonocular cancers; Staging; Systemic chemotherapy; Transpupillary thermotherapy

Indexed keywords

CARBOPLATIN; CYCLOSPORIN; EPIPODOPHYLLOTOXIN; ETOPOSIDE; GROWTH HORMONE; TENIPOSIDE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; BEAM THERAPY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER STAGING; CARCINOGENESIS; CHEMOTHERAPY INDUCED EMESIS; CHROMOSOMAL LOCALIZATION; CLINICAL TRIAL; CRYOTHERAPY; DIARRHEA; DRUG FEVER; ENUCLEATION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC COUNSELING; HEREDITY; HUMAN; HYPERTHERMIC THERAPY; LEUKOPENIA; NAUSEA; NONHUMAN; ONCOGENE; PRENATAL CARE; RETINOBLASTOMA; REVIEW; TRANSPUPILLARY THERMOTHERAPY; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CHILD; CHILD, PRESCHOOL; CRYOTHERAPY; GENETIC COUNSELING; HUMANS; HYPERTHERMIA, INDUCED; INCIDENCE; INFANT; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM STAGING; RETINAL NEOPLASMS; RETINOBLASTOMA; UNITED STATES;

EID: 10644267601     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200412000-00002     Document Type: Review

References (119)

1. Tamboli A, Podgor MJ, Horm JW. The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol 1990;108(1):128-32.
2. Pendergrass TW, Davis S. Incidence of retinoblastoma in the United States. Arch Ophthalmol 1980;98(7):1204-10.
3. Gatta G, Capocaccia R, Coleman MP, et al. Childhood cancer survival in Europe and the United States. Cancer 2002;95(8):1767-72.
4. Orjuela M, Castaneda VP, Ridaura C, et al. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res 2000;6(10):4010-6.
5. Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68(4):820-3.
6. Van Quill KR, O'Brien JM. The Role of the retinoblastoma protein in health, malignancy, and the pathogenesis of retinoblastoma. In: Albert DM, Polans A, eds. Ocular Oncology. New York: Marcel Dekker, Inc.; 2003:103-28.
7. Yunis JJ, Ramsay N. Retinoblastoma and subband deletion of chromosome 13. Am J Dis Child 1978;132(2):161-3.
8. Sparkes RS, Sparkes MC, Wilson MG, et al. Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14. Science 1980;208(4447):1042-4.
9. Connolly MJ, Payne RH, Johnson G, et al. Familial, EsD-linked, retinoblastoma with reduced penetrance and variable expressivity. Hum Genet 1983;65(2):122-4.
10. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323(6089):643-6.
11. Fung YK, Murphree AL, T'Ang A, et al. Structural evidence for the authenticity of the human retinoblastoma gene. Science 1987;236(4809):1657-61.
12. Dunn JM, Phillips RA, Becker AJ, Gallie BL. Identification of germline and somatic mutations affecting the retinoblastoma gene. Science 1988;241(4874):1797-800.
13. Dunn JM, Phillips RA, Zhu X, et al. Mutations in the RB1 gene and their effects on transcription. Mol Cell Biol 1989;9(11):4596-604.
14. Muncaster MM, Cohen BL, Phillips RA, Gallie BL. Failure of RB1 to reverse the malignant phenotype of human tumor cell lines. Cancer Res 1992;52(3):654-61.
15. Harbour JW. Overview of RB gene mutations in patients with retinoblastoma. Implications for clinical genetic screening. Ophthalmology 1998;105(8):1442-7.
16. Zhu X, Dunn JM, Goddard AD, et al. Mechanisms of loss of heterozygosity in retinoblastoma. Cytogenet Cell Genet 1992;59(4):248-52.
17. Wu L, de Bruin A, Saavedra HI, et al. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 2003;421(6926):942-7.
18. de Bruin A, Wu L, Saavedra HI, et al. Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice. Proc Natl Acad Sci 2003;100:6546-51.
19. Zhang J, Gray J, W L, et al. Rb regulates proliferation and rod photorecptor development in the mouse retina. Nat Genet 2004;36:351-60.
20. Maandag EC, van der Valk M, Vlaar M, et al. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. Embo J 1994;13(18):4260-8.
21. Williams BO, Schmitt EM, Remington L, et al. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. Embo J 1994;13(18):4251-9.
22. Zhang J, Schweers B, Dyer MA. The first knockout mouse model of retinoblastoma. Cell Cycle 2004;3:952-9.
23. Chen D, Gallie BL, Squire JA. Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 2001;129(1):57-63.
24. Doz F, Peter M, Schleiermacher G, et al. N-MYC amplification, loss of heterozygosity on the short arm of chromosome 1 and DNA ploidy in retinoblastoma. Eur J Cancer 1996;32A(4):645-9.
25. Mairal A, Pinglier E, Gilbert E, et al. Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses. Genes Chromosomes Cancer 2000;28(4):370-9.
26. Orjuela M, Castaneda VP, Ridaura C, et al. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res 2000;6:4010-16.
27. Palazzi MA, Yunes JA, Cardinalli IA, et al. Detection of oncogenic human papilloma virus in sporadic retinoblastoma. Acta Ophthalmol Scand 2003;81:396-98.
28. Mastrangelo D, Squitieri N, Bruni S, et al. The polymerase chain reaction (PCR) in the routine genetic characterization of retinoblastoma: a tool for the clinical laboratory. Surv Ophthalmol 1997;41(4):331-40.
29. Lohmann DR, Brandt B, Hopping W, et al. The spectrum of RB1 germ-line mutations in hereditary retinoblastoma. Am J Hum Genet 1996;58(5):940-9.
30. Scheffer H, te Meerman GJ, Kruize YC, et al. Linkage analysis of families with hereditary retinoblastoma: nonpenetrance of mutation, revealed by combined use of markers within and flanking the RB1 gene. Am J Hum Genet 1989;45(2):252-60.
31. Houdayer C, Gauthier-Villars M, Lauge A, et al. Comprehensive screening for constitutional RB1 mutations by DH-PLC and QMPSF. Hum Mutat 2004;23(2):193-202.
32. Bartova E, Kozubek S, Gajova H, et al. Cytogenetics and cytology of retinoblastomas. J Cancer Res Clin Oncol 2003;129(2):89-99.
33. Rotchell JM, Scoggins B, Blair JB, Ostrander GK. Isolation and characterization of the retinoblastoma protein from fish. Comp Biochem Physiol B Biochem Mol Biol 2001;130(3):385-91.
34. Smith BJ, O'Brien JM. The genetics of retinoblastoma and current diagnostic testing. J Pediatr Ophthalmol Strabismus 1996;33(2):120-3.
35. Rechitsky S, Verlinsky O, Chistokhina A, et al. Preimplantation genetic diagnosis for cancer predisposition. Reprod Biomed Online 2002;5:148-55.
36. Xu K, Rosenwaks Z, Beaverson K, Cholst I, Veeck L, Abramson DH. Preimplantation genetic diagnosis for retinoblastoma: the first reported liveborn. Am J Ophthalmol 2004;137(1):18-23.
37. Abramson DH, Schefler AC, Dunkel IJ, McCormick B, Dolphin KW. Neoplasms of the eye. In: Kufe DW, Pollack RE, Weichselbaum RR, et al., eds. Cancer Medicine. 6 ed. Hamilton: BC Decker, Inc.; 2003:1233-50.
38. Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. Am J Roentgenol 2001;176(2):289-96.
39. Gallie BL, Truong T, Heon E, et al. Retinoblastoma ABC classification survey. In: 11th International retinoblastoma symposium; 2003; Paris, France; 2003.
40. Shields CL, Mashayekhi A, Demirci H, Meadows AT, Shields JA. A simplified classification for retinoblastoma. In: 11th International retinoblastoma symposium; 2003; Paris, France; 2003.
41. Moll AC, Imhof SM, Meeteren AY, Boers M. At what age could screening for familial retinoblastoma be stopped? A register based study 1945-98. Br J Ophthalmol 2000;84:1170-1172.
42. Abramson DH. Treatment of retinoblastoma. In: Blodi FC, ed. Retinoblastoma. New York: Churchill Livingstone; 1985:3-93.
43. Abramson DH, Ellsworth RM. The surgical management of retinoblastoma. Ophthalmic Surg 1980;11(9):596-8.
44. Abramson DH, Schefler AC, Almeida D, Folberg R. Optic nerve tissue shrinkage during pathologic processing after enucleation for retinoblastoma. Arch Ophthalmol 2003;121:73-75.
45. Hadjistilianou T, Balestrazzi A, Mazzotta C, Mittica V, Caporossi A. Orbital implants in retinoblastoma patients. In: 11th International retinoblastoma symposium; 2003; Paris, France; 2003.
46. Abramson DH. Second nonocular cancers in retinoblastoma: a unified hypothesis. The Franceschetti Lecture. Ophthalmic Genet 1999;20:193-204.
47. Abramson DH, Melson MR, Dunkel IJ, Frank CM. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma. Ophthalmology 2001;108(10):1868-76.
48. Abramson DH, Frank CM. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology 1998;105(4):573-9; discussion 79-80.
49. Moll AC, Imhof SM, Schouten-Van Meeteren AY, Kuik DJ, Hofman P, Boers M. Second primary tumors in hereditary retinoblastoma: A register-based study, 1945-1997: is there an age effect on radiation-related risk? Ophthalmology 2001;108(6):1109-14.
50. Abramson DH, McCormick B, Schefler AC. Retinoblastoma. In: Leibel SA, Phillips TL, eds. Textbook of Radiation Oncology. 2 ed. Philadelphia: W.B. Saunders;2003:1463-81.
51. Zelter M, Damel A, Gonzalez G, Schwartz L. A prospective study on the treatment of retinoblastoma in 72 patients. Cancer 1991;68(8):1685-90.
52. Shidnia H, Hornback NB, Helveston EM, Gettlefinger T, Biglan AW. Treatment results of retinoblastoma at Indiana University Hospitals. Cancer 1977;40(6):2917-22.
53. Amendola BE, Markoe AM, Augsburger JJ, et al. Analysis of treatment results in 36 children with retinoblastoma treated by scleral plaque irradiation. Int J Radiat Oncol Biol Phys 1989;17(1):63-70.
54. Foote RL, Garretson BR, Schomberg PJ, Buskirk SJ, Robertson DM, Earle JD. External beam irradiation for retinoblastoma: patterns of failure and dose-response analysis. Int J Radiat Oncol Biol Phys 1989;16(3):823-30.
55. Bedford MA, Bedotto C, Macfaul PA. Retinoblastoma. A study of 139 cases. Br J Ophthalmol 1971;55(1):19-27.
56. Black L, McCormick B, Abramson DH. External beam radiation therapy and retinoblastoma: Long term results in the comparison of two techniques. Int J Radiat Oncol Biol Phys 1995;35:45.
57. Imhof SM, Mourits MP, Hofman P, et al. Quantification of orbital and mid-facial growth retardation after megavoltage external beam irradiation in children with retinoblastoma. Ophthalmology 1996;103(2):263-8.
58. Stallard HB. The conservative treatment of retinoblastoma. Highlights Ophthalmol 1963;6:129-30.
59. Shields JA, Shields CL. Intraocular tumors: a text and atlas. Philadelphia: Saunders; 1992.
60. Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B. Plaque radiotherapy for retinoblastoma: Long-term tumor control and treatment complications in 208 tumors. Ophthalmology 2001;108(11):2116-21.
61. Abramson DH, Ellsworth RM, Haik BG. Cobalt plaques in advanced retinoblastoma. Retina 1983;3:12-15.
62. Lagendijk JJ. A microwave heating technique for the hyperthermic treatment of tumours in the eye, especially retinoblastoma. Phys Med Biol 1982;27(11):1313-24.
63. Shields CL, Santos MC, Diniz W, et al. Thermotherapy for retinoblastoma. Arch Ophthalmol 1999;117(7):885-93.
64. Murphree AL, Villablanca JG, Deegan WF, 3rd, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 1996;114(11):1348-56.
65. Murphree AL, Munier FL. Retinoblastoma. In: Ryan SJ, ed. Retina. St. Louis: Mosby-Year Book Inc.; 1994:605-06.
66. Murray TG, O'Brien JM, Steeves RA, et al. Radiation therapy and ferromagnetic hyperthermia in the treatment of murine transgenic retinoblastoma. Arch Ophthalmol 1996;114(11):1376-81.
67. Murray TG, Cicciarelli N, McCabe CM, et al. In vitro efficacy of carboplatin and hyperthermia in a murine retinoblastoma cell line. Invest Ophthalmol Vis Sci 1997;38(12):2516-22.
68. Shields JA, Shields CL, De Potter P, Needle M. Bilateral macular retinoblastoma managed by chemoreduction and chemothermotherapy. Arch Ophthalmol 1996;114(11):1426-7.
69. Lueder GT, Goyal R. Visual function after laser hyperthermia and chemotherapy for macular retinoblastoma. Am J Ophthalmol 1996;121(5):582-4.
70. Levy C, Doz F, Quintana E, et al. Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results. Br J Ophthalmol 1998;82(10):1154-8.
71. Abramson DH, Schefler AC. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success. Ophthalmology 2004;111(5):984-91.
72. Lincoff H, McLean J, Long R. The cryosurgical treatment of intraocular tumors. Am J Ophthalmol 1967;63:389.
73. Neel HB, Ketcham AS, Hammond WG. Ischemia potentiating cryosurgery of primate liver. Ann Surg 1971;174(174):309-18.
74. Amoils SP. Cryosurgery in ophthalmology. Chicago: Yearbook Medical Publishers Inc.; 1975.
75. Bellman S, Adams RJ. Vascular reactions after experimental cold injury. Angiography 1956;7:339-67.
76. Mundth AD. Studies on the pathogenesis of cold injury: microcirculatory changes in tissue induced by freezing. Proc Symp Aretic Biol Med 1964;4(51-72).
77. Rabb JM, Renaud ML, Brandt PA, Witt CW. Effect of freezing and thawing on the microcirculation and capillary endothelium of the hampster cheek pouch. Cryobiol 1974;11:508-18.
78. Le Pivert PJ. Basic considerations of the cryolesion. Handbook of cryosurgery: Marcel Dekker Inc.; 1980.
79. Hopping W, Bunke-Schmidt A. Light coagulation and cryotherapy in retinoblastoma. In: Blodi FC, ed. Retinoblastoma. New York: Churchill Livingstone; 1985:95-110.
80. Abramson DH, Ellsworth RM, Rozakis GW. Cryotherapy for retinoblastoma. Arch Ophthalmol 1982;100(8):1253-6.
81. Shields JA, Parsons H, Shields CL, Giblin ME. The role of cryotherapy in the management of retinoblastoma. Am J Ophthalmol 1989;108(3):260-4.
82. Abramson DH. Cryotherapy in retinoblastoma. In: Jakobiec F, ed. Advanced techniques in ocular surgery. Philadelphia: WB Saunders Co.; 1984:433-37.
83. Kupfer C. Retinoblastoma treated with intravenous nitrogen mustard. Am J Ophthalmol 1953;36:1721.
84. Shields CL, Meadows AT, Shields JA, Carvalho C, Smith AF. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol 2001;119(9):1269-72.
85. Blach LE, McCormick B, Abramson DH, Ellsworth RM. Trilateral retinoblastoma-incidence and outcome: a decade of experience. Int J Radiat Oncol Biol Phys 1994;29(4):729-33.
86. Moll AC, Imhof SM, Schouten-Van Meeteren AY, Boers M. Screening for pineoblastoma in patients with retinoblastoma. Arch Ophthalmol 2002;120(12):1774; author reply 74.
87. Gallie BL, Budning A, DeBoer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 1996;114(11):1321-8.
88. Chan HS, DeBoer G, Thiessen JJ, et al. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res 1996;2(9):1499-508.
89. Kingston JE, Hungerford JL, Madreperla SA, Plowman PN. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 1996;114(11):1339-43.
90. Greenwald MJ, Strauss LC. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy. Ophthalmology 1996;103(12):1989-97.
91. Shields CL, De Potter P, Himelstein BP, Shields JA, Meadows AT, Maris JM. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 1996;114(11):1330-8.
92. Shields CL, Shields JA, Needle M, et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 1997;104(12):2101-11.
93. Gunduz K, Shields CL, Shields JA, et al. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma. Arch Ophthalmol 1998;116(12):1613-7.
94. Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000;18(1):12-7.
95. Wilson MW, Rodriguez-Galindo C, Haik BG, Moshfeghi DM, Merchant TE, Pratt CB. Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma. Ophthalmology 2001;108(11):2106-14; discussion 14-5.
96. Beck MN, Balmer A, Dessing C, Pica A, Munier F. First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma. J Clin Oncol 2000;18(15):2881-7.
97. Shields CL, Honavar SG, Meadows AT, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002;133:657-64.
98. Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 2002;120:460-64.
99. Brichard B, De Bruycker JJ, de Potter P, Neven B, Vermylen C, Cornu G. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. Med Pediatr Oncol 2002;38:411-15.
100. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ. Chemoreduction for unilateral retinoblastoma. Arch Ophthalmol 2002;120:1653-58.
101. Rodriguez-Galindo C, Wilson MW, Haik BG, et al. Treatment of intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol 2003;21:2019-25.
102. Anagnoste SR, Scott IU, Murray TG, Kramer D, Toledano S. Rhegmatogenous retinal detachment in retinoblastoma patients undergoing chemoreduction and cryotherapy. Am J Ophthalmol 2000;129(6):817-9.
103. Gombos DS, Howes E, O'Brien JM. Cholesterosis following chemoreduction for advanced retinoblastoma. Arch Ophthalmol 2000;118(3):440-1.
104. Scott IU, Murray TG, Toledano S, O'Brien JM. New retinoblastoma tumors in children undergoing systemic chemotherapy. Arch Ophthalmol 1998;116(12):1685-6.
105. Lee TC, Hayashi NI, Dunkel IJ, Beaverson K, Novetsky D, Abramson DH. New retinoblastoma tumor formation in children treated initially with systemic carboplatin. Ophthalmology 2003;110:1989-94.
106. Travis LB, Curtis RE, Stovall M, et al. Risk of leukemia following treatment for non-Hodgkin's lymphoma. J Natl Cancer Inst 1994;86(19):1450-7.
107. Hawkins MM, Wilson LM, Stovall MA, et al. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. BMJ 1992;304(6832): 951-8.
108. Rivera GK, Pui CH, Santana VM, Pratt CB, Crist WM. Epipodophyllotoxins in the treatment of childhood cancer. Cancer Chemother Pharmacol 1994;34(Suppl):S89-95.
109. Gombos DS, Hungerford JL, Kingston JE, et al. Secondary AML in patients with retinoblastoma. In: 11th International retinoblastoma symposium; 2003; Paris, France; 2003.
110. Finger PT. Chemotherapy for retinoblastoma. Drugs 1999;58(6):983-96.
111. Harbour JW, Murray TG, Hamasaki D, et al. Local carboplatin therapy in transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci 1996;37(9):1892-8.
112. Murray TG, Cicciarelli N, O'Brien JM, et al. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma. Arch Ophthalmol 1997;115(10):1286-90.
113. Mendelsohn ME, Abramson DH, Madden T, Tong W, Tran HT, Dunkel IJ. Intraocular concentrations of chemotherapeutic agents after systemic or local administration. Arch Ophthalmol 1998;116(9):1209-12.
114. Mulvihill A, Budning A, Jay V, et al. Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma. Arch Ophthalmol 2003;121(8):1120-4.
115. Sklar CA, Mertens AC, Mitby P, et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002;87:3136-41.
116. Abramson DH, Lee TC, Driscoll C. Osteogenic sarcoma in a survivor of metastatic germline retinoblastoma: the possible influence of human growth hormone. J Pediatr Ophthalmol Strabismus 2002;39:347-48.
117. Wong FL, Boice JD, Jr., Abramson DH, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 1997;278(15):1262-7.
118. Kleinerman RA, Tarone RE, Abramson DH, Seddon JM, Li FP, Tucker MA. Hereditary retinoblastoma and risk of lung cancer. J Natl Cancer Inst 2000;92(24):2037-9.
119. Li FP, Abramson DH, Tarone RE, Kleinerman RA, Fraumeni JF, Jr., Boice JD, Jr. Hereditary retinoblastoma, lipoma, and second primary cancers. J Natl Cancer Inst 1997;89(1):83-4.